Jump to Header Jump to Main Content Jump to Footer

trials found matching your search:


Displaying 20 of 280 Results
Age
Type
Conditions or Disease:

PhII NanO2TM Combo w/Rad&Temozolomide Pa w/NewlyDia GlioblsdtomaMultiforme: RESTORE

Xiao-Tang Kong

  • OPEN TO ACCRUAL

PhIII TOOKAD (Padeliporfin) Vascular Targeted Photodynamic Therapy Tx of Upper Tract Urothelial Ca

Edward Uchio

  • OPEN TO ACCRUAL

NEO-RT Trial:PhIII RandomNeoadjChemo Excision&Obs Vs Chemoradiothe forEarly RectalCa

Jason Zell

  • OPEN TO ACCRUAL

PhII Daratumumab Selinexor Velcade Dexamethasone HighRisk New Dx MultipleMyeloma

Lisa Xingguang Lee

  • OPEN TO ACCRUAL

PhIb/II Open-Label Study Disitamab Vedotin Monother or inCombination w/OtherAntica Therapies SolidTu

Farshid Dayyani

  • OPEN TO ACCRUAL

OptimicePCR:DeescalationThe EarlStageTNBCPa whoAchievePCR AfterNeoadj Chemothe w/Checkpoint InhibThe

Ritesh Parajuli

  • OPEN TO ACCRUAL

EarlyPh&PhII TrialEvaluateGangliosideMonosialicAcid PreventPaclitaxelAssociatedNeuropathy

Ritesh Parajuli

  • OPEN TO ACCRUAL

Ph II/III of Calaspargase Pegol for Tx of Adults Aged 22 to >65 Years w/ New Diagnose Ph- ALL

Deepa Jeyakumar

  • OPEN TO ACCRUAL

Ph I/II Peposertib in Combo w/Hypofractionated Radiotherapy for Tx of Adv Pancreatic Adenocarcinoma

Farshid Dayyani

  • OPEN TO ACCRUAL

Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leu

Mahtab Jafari

  • OPEN TO ACCRUAL

Double-Blind use of Staccato Alprazolam for participants with prolonged seizures

Lilit Mnatsakanyan

  • OPEN TO ACCRUAL

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in participants with IPF

Huawei Dong

  • OPEN TO ACCRUAL

A Study of BMS-986278 in Participants with Progressive Pulmonary Fibrosis

Huawei Dong

  • OPEN TO ACCRUAL

Prospective, Multi-Center, Randomized, Sham-Controlled Clinical Trial for Heart Failure

Antonio Frangieh

  • OPEN TO ACCRUAL

Determine effectiveness of Anifrolumab in Systemic sclerosis (DAISY)

Priyanka Iyer

  • OPEN TO ACCRUAL

Phase 3 Trial to Evaluate Ianalumab in Patients with Active Lupus Nephritis

Sheetal Desai

  • OPEN TO ACCRUAL

Phase 2 Study to Evaluate Efavaleukin Alfa in Subjects with Moderate to Severe Active UC

Sandra Park

  • OPEN TO ACCRUAL

PhI KT-333 in Adult Patients w/ R/R Lymphomas, Large Granular Lymphocytic Leukemia, & Solid Tumors

Lauren C Pinter-Brown

  • OPEN TO ACCRUAL